You are here
Nexbio, Inc.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Proof-of-Principle Studies of DAS181 for Parainfluenza Virus Infection
Amount: $299,998.00DESCRIPTION (provided by applicant): Broad-spectrum prophylaxis and therapeutics for respiratory viral infections are highly desirable due to the immense socioeconomic burden imposed by the respirator ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
Development of Fludase for Prevention of Influenza
Amount: $6,000,000.00DESCRIPTION (provided by applicant): Influenza is characterized by recurrent annual epidemics and periodic major worldwide pandemics. Because of the high disease-related morbidity and mortality, dire ...
SBIRPhase II2005Department of Health and Human Services National Institutes of Health -
Identifying Broad-Spectrum Influenza Virus Inhibitors
Amount: $812,013.00DESCRIPTION (provided by applicant): Broad-spectrum therapeutics for influenza is critically needed to address the problem of influenza pandemics, a major threat to the public health globally. We have ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Novel Therapeutics for Pandemic and Epidemic Flu
Amount: $1,000,000.00DESCRIPTION (provided by applicant): Broad-spectrum therapeutics for influenza are critically needed to address the problem of influenza pandemics, a major threat to the public health globally. We hav ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Broad-Spectrum Therapeutics for Influenza
Amount: $918,265.00DESCRIPTION (provided by applicant): Influenza is a highly infectious acute respiratory disease that has plagued the human race since ancient times. It is characterized by recurrent annual epidemics ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health
